Dexcom reported $770.7M in Stock for its fiscal quarter ending in September of 2026.





Stock Change Date
Abbott USD 7.34B 22M Sep/2026
Align Technology USD 212.24M 2.7M Jun/2026
AtriCure USD 87.31M 3.38M Sep/2026
Baxter International USD 2.3B 41M Sep/2026
Becton, Dickinson and Co. USD 3.19B 125M Sep/2026
Boston Scientific USD 3.32B 82M Sep/2026
Cooper Companies USD 896.4M 20M Mar/2026
Dexcom USD 770.7M 44.3M Sep/2026
Edwards Lifesciences USD 1.16B 28.2M Sep/2026
Globus Medical USD 824.14M 13.25M Sep/2026
Inogen USD 25.08M 762K Sep/2025
Insulet USD 552.1M 67.3M Sep/2026
Integra LifeSciences USD 464.45M 27.55M Sep/2026
J&J USD 15.38B 233M Sep/2026
Medtronic USD 6.22B 264M Jun/2026
Merit Medical Systems USD 391.02M 16.91M Sep/2026
Roche Holding CHF 7.6B 9M Jun/2025
Solventum Corp USD 1.1B 62M Sep/2026
Stryker USD 5.75B 226M Sep/2026
Tandem Diabetes Care USD 143.12M 8.01M Sep/2026
Teleflex USD 384.42M 32.5M Sep/2026
West Pharmaceutical Services USD 464.7M 17.3M Sep/2026
Zimmer Biomet Holdings USD 2.37B 96.9M Sep/2026